MFZ - Medizinisches Forschungszentrum, 2. OG, Raum 2.022
Biosketch / Snapshot
Tanvi Khera graduated with bachelor’s degree in Biotechnology from New Delhi, India and completed her M.Phil. in Life sciences from International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy. Thereafter she received her PhD in 2017 from the Medical School Hannover, Germany under the mentorship of Prof. Dr. Thomas Pietschmann. During her doctoral studies she investigated the antibody mediated immune responses for Hepatitis C virus (HCV) in the context of vaccine development and studied viral transmission using cutting edge next generation sequencing (NGS) technology. Since 2018, she joined Prof. Dr. Heiner Wedemeyer as a Post-doctoral researcher. Her present research focusses on ‘Immunopathogenesis of viral hepatitis’. During this, she also spent three months at the Karolinska Institute, Stockholm, Sweden to study the impact of antiviral therapy on natural killer cell diversity and T cell responses following HCV infection.